Advertisement

Topics

Ivantis Inc. Company Profile

18:27 EDT 17th June 2018 | BioPortfolio

Ivantis, Inc. is a privately held company established in 2007 to design, develop and commercialize new technologies to treat eye disease. Investors include New Enterprise Associates, Delphi Ventures, and Ascension Health Ventures.


News Articles [3 Associated News Articles listed on BioPortfolio]

Glaukos files patent lawsuit against Ivantis

Glaukos Corporation filed a patent infringement lawsuit against Ivantis Inc., according to a company press release.Filed in the U.S. District Court for the Central District of California, Southern Div...

Ivantis Announces Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial

COMPARE is the first prospective, multi-center, randomized trial comparing two MIGS devices, the Hydrus Microstent versus two large-diameter iStent® Trabecular Micro-bypass stents, for the treatmen...

Glaukos Files Patent Infringement Lawsuit Against Ivantis, Inc.

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to tra...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

MIGS VS SLT Comparison in Glaucoma Patients

To compare the intraocular pressure (IOP) and number of glaucoma medications lowering of microinvasive glaucoma surgery (MIGS) with the implantation of the trabecular device Hydrus (Ivanti...

Companies [2 Associated Companies listed on BioPortfolio]

Ivantis, Inc.

Ivantis, Inc. is a privately held company established in 2007 to design, develop and commercialize new technologies to treat eye disease. Investors include New Enterprise Associat...

Ivantis Inc.

Ivantis, Inc. is a privately held company established in 2007 to design, develop and commercialize new technologies to treat eye disease. Investors include New Enterprise Associat...

More Information about "Ivantis Inc." on BioPortfolio

We have published hundreds of Ivantis Inc. news stories on BioPortfolio along with dozens of Ivantis Inc. Clinical Trials and PubMed Articles about Ivantis Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ivantis Inc. Companies in our database. You can also find out about relevant Ivantis Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record